Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "Asciminib Combined With Dasatinib and Prednisone for BCR-ABL1+ ALL and Blast Phase CML in Adults"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Marlise R. Luskin
By
Insights from 2023 ASH Annual Meeting
FEATURING
Marlise R. Luskin
205 views
December 20, 2023
Comments 0
Login to view comments.
Click here to Login
Leukemia